Seeds Capital
VC Fund
Singapore, Singapore
Seeds Capital is an investment arm of Enterprise Singapore that co-invests with independent investors in innovative startups. The firm was founded in 1992 and is headquartered in Central Region, Singapore.
- Total investments:
- 150
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries Seeds Capital invests in
Stages Seeds Capital invests in
Countries Seeds Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $767k–$6.8M
- Series A
- $2.4M–$21M
- Series B
- $5M–$45M
Investment Focus
Industry
- Biotechnology 27 (18%)
- Artificial Intelligence 25 (17%)
- Health Care 24 (16%)
- Software 23 (15%)
- Information Technology 19 (13%)
Stage
- Seed 60 (40%)
- Series A 43 (29%)
- Series B 10 (7%)
- Funding Round 8 (5%)
- Venture - Series Unknown 7 (5%)
Country
- Singapore 99 (66%)
- United States 7 (5%)
- Hong Kong 2 (1%)
- India 1 (1%)
- Canada 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Kaixin Tan
General Manager
|
General Manager | Total investments: 8 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Nexstrom is a semiconductor technology company developing wafer-scale 2D semiconductor technology and manufacturing systems for next-generation computing. Its technology is designed to address the high transistor density and energy efficiency requirements of AI infrastructure, supporting the development of advanced computing hardware for AI and other applications. | $12M / Seed / Sep 22, 2026 | ||
| They offer platforms that are able to report clinical deterioration and provide recommended interventions with post-monitoring.They work in the health care industry, just like you. We take the time to get to know you, and we always keep your best interests in mind when adding and adjusting products in our catalog. | Series A / Sep 21, 2026 | ||
| N&E Innovations is a med-tech company that develops antimicrobial products. | $1.7M / Series A / Sep 09, 2026 | ||
| The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development. | $4M / Seed / Jun 22, 2026 | ||
| Pints.ai provides a on-prem plug-n-play AI solution tailored for financial institutions, ensuring utmost confidentiality and secure handling of data. Merging the strengths of our proprietary large model, with industry-specific features, our Neuron AI is pre-trained in financial knowledge and seamlessly integrates with our clients' sensitivedata. We swiftly empower financial entities, from retail banks to fintech startups, enhancing their sales and operations for a competitive, secure advantage. | $5.6M / Seed / Jun 15, 2026 | ||
| Pinta AI provides an AI security platform focused on monitoring and controlling AI agents, coding tools, and Model Context Protocol workflows. The platform operates at the runtime layer to track prompts, tool calls, JSON-RPC messages, and outcomes tied to individual users. It gives security teams execution visibility across servers, agents, tools,and resources, including unauthorized or shadow AI setups. Pinta AI detects risky or high-impact actions such as access to sensitive data or critical system resources and surfaces them as security alerts. The software maintains detailed audit trails with identity, tools, timestamps, and actions to support investigation and compliance. It is designed to integrate with existing AI stacks and security operations without requiring major changes to current workflows. | $5.6M / Seed / Jun 15, 2026 | ||
| SG Enviro is an environmental services company that provides solutions for industrial waste water management. | Series A / May 29, 2026 | ||
| Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases. | $6.8M / Seed / May 06, 2026 | ||
| Datakrew is a spinoff deep-tech company from Nanyang Technological University, Singapore with strong roots in Internet-of-Thing (IoT), Artificial Intelligence (AI) and Data Security. We enable large-scale secure IoT applications through data-driven Monitoring, Automation, Diagnostics and Security – MADS while ensuring military-grade data privacyand security | $2.6M / Seed / Mar 18, 2026 | ||
| Polybee develops autonomous drone systems designed for agricultural applications. They focus on automating yield forecasting and pollination using drones, computer vision, and artificial intelligence. Their technology aims to reduce uncertainty in agriculture by providing solutions for seed companies, vertical farming operations, and greenhousecooperatives. Polybee's innovations are particularly useful in environments. | $4.3M / Seed / Feb 09, 2026 | ||
| See all 150 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Seeds Capital invest in?
Seeds Capital invests primarily in Biotechnology, Artificial Intelligence and Health Care startups, most often at Seed and Series A stage. Most of the 150 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Seeds Capital invest in?
Seeds Capital typically joins rounds of $767k–$6.8M at Seed, $2.4M–$21M at Series A and $5M–$45M at Series B. These are whole funding-round sizes, not Seeds Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Seeds Capital took part in.
How do I contact Seeds Capital?
Public channels for Seeds Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Seeds Capital?
The team at Seeds Capital includes Kaixin Tan (General Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
